These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6389282)

  • 1. [Changes in hemorheologic and physiologic coagulation parameters in different methods of therapy of retinal vascular disorders--a randomized double-blind study].
    Heinen A; Brunner R; Hossmann V; Konen W; Roll K; Wawer T
    Fortschr Ophthalmol; 1984; 81(5):444-8. PubMed ID: 6389282
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of retinal vascular disorders by modification of blood viscosity--a randomized double-blind study].
    Brunner R; Heinen A; Konen W; Hossmann V; Gaethgens P
    Fortschr Ophthalmol; 1984; 81(5):440-3. PubMed ID: 6389281
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
    Mozzi E; Annoni F; Chiurazzi D; Rossi R; Pacini F; Martini A
    Minerva Cardioangiol; 1984 Mar; 32(3):141-9. PubMed ID: 6374499
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
    Ciuffetti G; Mercuri M; Susta A; Lupattelli G; Pasqualini L; Lombardini R; Mannarino E
    Angiology; 1989 Apr; 40(4 Pt 1):255-9. PubMed ID: 2705632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of contrast media on rheological parameters: an in vivo study.
    Acciavatti A; Galigani C; Pieragalli D; Baldi C; Di Perri T
    Rays; 1987; 12(3):55-60. PubMed ID: 3503329
    [No Abstract]   [Full Text] [Related]  

  • 6. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients.
    Aiello LP; Clermont A; Arora V; Davis MD; Sheetz MJ; Bursell SE
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):86-92. PubMed ID: 16384948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of calcium dobesilate (Doxium) on blood viscosity and coagulation parameters in diabetic retinopathy.
    Vinazzer H; Hachen HJ
    Vasa; 1987; 16(2):190-2. PubMed ID: 3300085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of molsidomine on rheological parameters and the incidence of cardiovascular events].
    Wöhrle J; Nusser T; Hoffmeister A; Kestler HA; Grebe OC; Höher M; Hombach V; Koenig W; Kochs M
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1333-7. PubMed ID: 12802741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the determination of several hemostatic parameters in the lacrimal fluid of patients with vascular diseases of the retina].
    Mukha AI; Markova OA
    Vestn Oftalmol; 1994; 110(1):19-20. PubMed ID: 8191655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity.
    Sonkin PL; Sinclair SH; Hatchell DL
    Am J Ophthalmol; 1993 Jun; 115(6):775-80. PubMed ID: 8506913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on diabetic retinal vascular changes with special reference to blood coagulation and viscosity.
    Labib MA; Higazi AM; el-Ebrashy N; el-Ashmawy S; Madkour MK; Barhooma GA
    Bull Ophthalmol Soc Egypt; 1971; 64(68):457-82. PubMed ID: 5154745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorheologic study of different forms of vasomotor acrosyndromes].
    Sarrat P; Serise JM; Freyburger G; Lorient-Roudaut MF; Boisseau MR
    J Mal Vasc; 1987; 12(1):113-6. PubMed ID: 3559405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation disorders in retinal periphlebitis].
    Kühl W
    Dtsch Gesundheitsw; 1972 Jan; 27(4):168-70. PubMed ID: 5019147
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemorheology and peripheral vascular diseases: a new therapeutic approach.
    Müller R
    J Med; 1981; 12(4):209-35. PubMed ID: 7031157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect on the eye vessels of vasodilator agents after their administration by different electrophoretic methods (clinical study)].
    Nurieva SM
    Vestn Oftalmol; 1978; (2):71-3. PubMed ID: 349832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
    Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
    G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of pridazol on the level of pressure in the central retinal artery].
    Jakubowska-Pakulowa D; Duszowa J
    Klin Oczna; 1968; 38(2):343-7. PubMed ID: 4876142
    [No Abstract]   [Full Text] [Related]  

  • 19. [A preparation for the therapy of ischemic arterial diseases].
    Mueller-Duesberg P
    Med Klin; 1981 Mar; 76(7):197-9. PubMed ID: 7231334
    [No Abstract]   [Full Text] [Related]  

  • 20. C-peptide does not affect ocular blood flow in patients with type 1 diabetes.
    Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L
    Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.